{"id":"NCT04880642","sponsor":"Vicore Pharma AB","briefTitle":"A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 3, Multicenter Trial Investigating the Efficacy and Safety of C21 as add-on to Standard of Care in Adult Subjects With COVID-19","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-09-16","primaryCompletion":"2022-04-25","completion":"2022-04-25","firstPosted":"2021-05-11","resultsPosted":"2023-12-14","lastUpdate":"2023-12-14"},"enrollment":272,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["COVID-19"],"interventions":[{"type":"DRUG","name":"C21","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"C21","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This trial is a randomized, double-blind, placebo-controlled, parallel-group, 2-arm, multicenter trial to evaluate the efficacy and safety of C21 versus placebo as add-on to standard of care (SoC) in adult subjects with COVID-19.\n\nThe trial planned to enroll a total of maximum 300 randomized subjects, 150 per arm (oral C21 100 mg twice a day (BID) or placebo for 14 days) according to the 1:1 randomization.","primaryOutcome":{"measure":"All-cause Mortality up to Day 60","timeFrame":"Day 1 to Day 60","effectByArm":[{"arm":"C21 Treatment","deltaMin":10,"sd":null},{"arm":"Placebo Treatment","deltaMin":10,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.949"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":60,"countries":["United States","Argentina","Brazil","Colombia","Czechia","India","Philippines","Russia","South Africa","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":134},"commonTop":["Alanine aminotransferase increased","Nausea","Pyrexia","Headache","Asthenia"]}}